Indications
treatment of diabetes mellitus
Composition
- Active substance
- insulin human
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Isomarv medium
- Active substance
- insulin human
- Marketing authorisation holder
- Marvel Life Sciences Ltd.
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/002610
EMA designations
- Orphan medicine
- No
- Conditional approval
- No
- Biosimilar
- No
- Generic
- No
- Accelerated assessment
- No
- Additional monitoring
- No
- Patient safety information
- No